With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...

Enveloped viruses have tremendous potential in a number of areas of great interest to biotech and pharma firms including gene therapy and vaccination. These viruses, which are typically produced in ...

New addition enhances manufacturing continuity and supports seamless progression from early-phase development to late-stage ...

Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient according to new ...

According to MarketsandMarkets™, the Human Microbiome Manufacturing Services Market is projected to grow from about USD 0.11 billion in 2025 ...